Imexpharm Stock

Imexpharm EBIT per Share

EBIT per Share of Imexpharm (IMP.VN) as of Sep 10, 2026.

EBIT per Share

0.00VND

Last updated:

EBIT per Share of Imexpharm is 2026 0.00 VND. EBIT per Share of Imexpharm was 2025 0.00 VND. It decreases by % lower compared to the previous year.

The Imexpharm EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2013
2,685.39 VND
Jan 1, 2014
3,056.47 VND
Jan 1, 2015
2,129.96 VND
Jan 1, 2016
2,431.36 VND
Jan 1, 2017
2,076.58 VND
Jan 1, 2018
2,466.22 VND
Jan 1, 2026 (e)
8,896.09 VND
Jan 1, 2027 (e)
10,112.30 VND
The Imexpharm EBIT per Share history
YEAREBIT per ShareYoY
est10,112.30VND+13.67%
est8,896.09VND+260.72%
2,466.22VND+18.76%
2,076.58VND-14.59%
2,431.36VND+14.15%
2,129.96VND-30.31%
3,056.47VND+13.82%
2,685.39VND-15.22%
3,167.48VND-2.85%
3,260.47VND-3.35%
3,373.34VND+16.34%
2,899.52VND+17.64%
2,464.83VND+0.33%
2,456.61VND+26.04%
1,949.13VND—
Access this data via the Eulerpool API
Get Free API Key

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

On Eulerpool you can find the complete historical development of EBIT per Share Imexpharm since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Imexpharm

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Imexpharm